
Conference Coverage
Latest Content

PD-1, PD-L1 Agents Improve Outcomes for Cutaneous Squamous Cell Carcinoma: Todd Schlesinger, MD

AI-Driven Chart Review Improves Identification of ATTR-CM Trial Candidates

Teclistamab Combo Approved by FDA for R/R MM

Neighborhood Opportunities and Pediatric Health Care Utilization: Implications for Medicaid Managed Care

GLP-1s Reduced Risk of Developing Substance Use Disorders

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

The rise in CRC in adults younger than 65 underscores the need for early screening and prevention efforts.

The Inflation Reduction Act introduced Medicare drug price negotiations to reduce treatment costs, enhance access, and potentially reshape prescribing patterns in oncology and hematology.

Patient-reported data can predict survival in leukemia, and integrating measuring tools improves care by prioritizing the patient's perspective.

A study of 1.5 million patients suggests that ACA Medicaid expansion reduces breast cancer deaths, especially advanced cases—yet racial and income gaps persist.

The approval is expected to offer more affordable treatment options and potentially reduce asthma-related complications nationwide.

The Support, Educate, Empower intervention was able to reduce glaucoma-related distress compared with standard education.

A new science-focused autism committee mobilizes against controversial federal appointments.

Wildfire smoke from the Canadian wildfires in 2023 was linked to a higher incidence of severe strokes and increased hemorrhagic risk, according to new study findings.

A Winter Clinical Miami poster highlights intralesional cemiplimab for early CSCC, showing rapid responses and positive safety vs surgery.

These new data highlight CRC screening gaps, as well as disparities in incidence and survival.






























